NeuroSense Therapeutics (NRSN) F-1 Registration statement (foreign)

Exhibit 99.1

In connection with the filing by NeuroSense Therapeutics Ltd. of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of NeuroSense Therapeutics Ltd. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.

Dated: October 18, 2021

/s/ Cary Claiborne

Cary Claiborne